Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy

By Davis Keith L.   Tangirala Muralikrishna   Meyers Juliana L.   Wei Wenhui  

Current Medical Research and Opinion, Vol. 29, Iss. 9, 2013-09 ,pp. : 1083-1091

Informa Healthcare

Access to resources Recommend Favorite

A Real‐World Study of the Effect of Timing of Insulin Initiation on Outcomes in Older Medicare Beneficiaries with Type 2 Diabetes Mellitus

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 5, 2015-05 ,pp. : 893-901

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies

By Xie Lin   Wei Wenhui   Pan Chunshen   Baser Onur  

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1137-1145

Informa Healthcare

Access to resources Recommend Favorite

The effectiveness of insulin initiation regimens in patients with type 2 diabetes mellitus: a large national medical records review study comparing a basal insulin analogue to premixed insulin

By Sun Peter   Wang Ruoping   Jacober Scott  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3017-3023

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes

By Levin Philip   Wei Wenhui   Wang Li   Pan Chunshen   Douglas Damon   Baser Onur  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 439-446

Informa Healthcare

Access to resources Recommend Favorite